Bravo SG

No ORCID on file · 1 paper in corpus

observational 2026

The impact of antinuclear antibodies and complement levels in the prognosis of pregnant women within the antiphospholipid syndrome spectrum

Frontiers in immunology ·doi:10.3389/fimmu.2026.1818605

INTRODUCTION: To assess the prevalence and clinical impact of antinuclear antibodies (ANA) and low complement levels on fetal-maternal outcomes in pregnant women within the spectrum of obstetric antiphospholipid syndrome (APS). METHODS: A …